Suppr超能文献

α-肾上腺素能受体拮抗剂对体外胰腺癌细胞凋亡和增殖的影响。

Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.

作者信息

Shen Su-Gang, Zhang Dong, Hu Heng-Tong, Li Jun-Hui, Wang Zheng, Ma Qing-Yong

机构信息

Department of Hepatobiliary and Pancreas Surgery, the First Affiliated Hospital, Medical College, Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.

出版信息

World J Gastroenterol. 2008 Apr 21;14(15):2358-63. doi: 10.3748/wjg.14.2358.

Abstract

AIM

To discuss the expression of alpha-adrenoreceptors in pancreatic cancer cell lines PC-2 and PC-3 and the effects of alpha1- and alpha2-adrenoreceptor antagonists, yohimbine and urapidil hydrochloride, on the cell lines in vitro.

METHODS

We cultured the human ductal pancreatic adenocarcinoma cell lines PC-2 and PC-3 and analyzed the mRNA expression of alpha1- and alpha2-adrenergic receptors by reverse transcription polymerase chain reaction (RT-PCR). The effects of yohimbine and urapidil hydrochloride on cell proliferation were assessed by 3-(4,5-dimethylthiasol-2-yl)-2,4,-diphenyltetrazolium bromide (MTT) assay. Apoptosis was detected using the terminal deoxyribonucleotidyl transferase (TdT)-mediated biotin-16-dUTP nick-end labeling (TUNEL) assay and flow cytometry (FCM).

RESULTS

PC-2 expressed mRNA in alpha1- and alpha2-adrenoreceptors. MTT assays showed that urapidil hydrochloride had no effect on PC-3 cell lines. However, exposure to urapidil hydrochloride increased DNA synthesis in PC-2 cell lines as compared to the control group. PC-2 cell lines were sensitive to both drugs. The proliferation of the 2 cell lines was inhibited by yohimbine. Cell proliferation was inhibited by yohimbine via apoptosis induction.

CONCLUSION

The expression of alpha1- and alpha2-adrenoreceptors is different in PC-2 and PC-3 cell lines, which might be indicative of their different functions. The alpha2-adrenoceptor antagonist, yohimbine, can inhibit the proliferation of both cell lines and induce their apoptosis, suggesting that yohimbine can be used as an anticancer drug for apoptosis of PC-2 and PC-3 cells.

摘要

目的

探讨α-肾上腺素能受体在胰腺癌细胞系PC-2和PC-3中的表达,以及α1-和α2-肾上腺素能受体拮抗剂育亨宾和盐酸乌拉地尔对这些细胞系的体外作用。

方法

培养人胰腺导管腺癌细胞系PC-2和PC-3,采用逆转录聚合酶链反应(RT-PCR)分析α1-和α2-肾上腺素能受体的mRNA表达。通过3-(4,5-二甲基噻唑-2-基)-2,4-二苯基四氮唑溴盐(MTT)法评估育亨宾和盐酸乌拉地尔对细胞增殖的影响。使用末端脱氧核苷酸转移酶(TdT)介导的生物素-16-dUTP缺口末端标记(TUNEL)法和流式细胞术(FCM)检测细胞凋亡。

结果

PC-2表达α1-和α2-肾上腺素能受体的mRNA。MTT试验表明,盐酸乌拉地尔对PC-3细胞系无影响。然而,与对照组相比,盐酸乌拉地尔处理使PC-2细胞系中的DNA合成增加。PC-2细胞系对两种药物均敏感。育亨宾抑制这两种细胞系的增殖。育亨宾通过诱导凋亡抑制细胞增殖。

结论

PC-2和PC-3细胞系中α1-和α2-肾上腺素能受体的表达不同,这可能表明它们具有不同的功能。α2-肾上腺素能受体拮抗剂育亨宾可抑制两种细胞系的增殖并诱导其凋亡,提示育亨宾可作为PC-2和PC-3细胞凋亡的抗癌药物。

相似文献

1
Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.
World J Gastroenterol. 2008 Apr 21;14(15):2358-63. doi: 10.3748/wjg.14.2358.
3
Alpha1A-adrenergic receptors mediate vasoconstriction of the isolated spiral modiolar artery in vitro.
Hear Res. 1998 May;119(1-2):113-24. doi: 10.1016/s0378-5955(98)00036-7.
4
Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice.
Br J Pharmacol. 2008 Oct;155(4):494-504. doi: 10.1038/bjp.2008.278. Epub 2008 Jul 7.
7
Functional alpha2C-adrenoceptors in human neuroblastoma SH-SY5Y cells.
Eur J Pharmacol. 1999 May 7;372(1):109-15. doi: 10.1016/s0014-2999(99)00190-9.
8
Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.
Psychopharmacology (Berl). 2005 Jul;180(3):491-500. doi: 10.1007/s00213-005-2193-7. Epub 2005 Feb 18.
10
Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting.
Circulation. 2002 Dec 3;106(23):2901-7. doi: 10.1161/01.cir.0000040998.88272.a7.

引用本文的文献

2
Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates.
FEBS Open Bio. 2024 May;14(5):803-830. doi: 10.1002/2211-5463.13796. Epub 2024 Mar 26.
4
A literature perspective on the pharmacological applications of yohimbine.
Ann Med. 2022 Dec;54(1):2861-2875. doi: 10.1080/07853890.2022.2131330.
5
Anticancer potential of yohimbine in drug-resistant oral cancer KB-ChR-8-5 cells.
Mol Biol Rep. 2022 Oct;49(10):9565-9573. doi: 10.1007/s11033-022-07847-7. Epub 2022 Aug 16.
7
Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from : Possible Implication in Cancer Therapy.
Evid Based Complement Alternat Med. 2022 Mar 23;2022:3787162. doi: 10.1155/2022/3787162. eCollection 2022.
8
Elucidating Antiangiogenic Potential of : VEGFR-2 Targeting-Based Molecular Docking Study.
Evid Based Complement Alternat Med. 2022 Feb 14;2022:6224666. doi: 10.1155/2022/6224666. eCollection 2022.
10
Synthesis of Conformationally Liberated Yohimbine Analogues and Evaluation of Cytotoxic Activity.
ACS Omega. 2021 Jul 13;6(29):19291-19303. doi: 10.1021/acsomega.1c02784. eCollection 2021 Jul 27.

本文引用的文献

1
Adrenergic Receptors From Molecular Structure to in vivo function.
Trends Cardiovasc Med. 1997 Jul;7(5):137-45. doi: 10.1016/S1050-1738(97)00034-0.
2
Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma.
Pancreatology. 2007;7(5-6):459-69. doi: 10.1159/000108963. Epub 2007 Oct 1.
3
Surgery insight: surgical management of pancreatic cancer.
Nat Clin Pract Oncol. 2007 Sep;4(9):526-35. doi: 10.1038/ncponc0925.
5
Current therapies and advances in the treatment of pancreatic cancer.
Crit Rev Oncol Hematol. 2006 Jun;58(3):231-41. doi: 10.1016/j.critrevonc.2006.02.004. Epub 2006 May 24.
6
Epidemiology and risk factors for pancreatic cancer.
Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):197-209. doi: 10.1016/j.bpg.2005.10.001.
7
Human breast cell lines exhibit functional alpha2-adrenoceptors.
Cancer Chemother Pharmacol. 2006 Jul;58(1):50-61. doi: 10.1007/s00280-005-0130-4. Epub 2005 Nov 15.
8
Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies.
Pancreas. 2005 Nov;31(4):301-16. doi: 10.1097/01.mpa.0000175893.04660.1b.
9
Identification of functional beta-adrenoceptors in Caco-2 cell membranes.
Vet Res Commun. 2003 Sep;27 Suppl 1:415-8. doi: 10.1023/b:verc.0000014193.33395.69.
10
Evaluation of beta-adrenergic receptor subtypes in the human prostate cancer cell line-LNCaP.
Biochem Pharmacol. 2003 May 1;65(9):1489-94. doi: 10.1016/s0006-2952(03)00105-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验